-
Sep 15, 2020, 03:50 AM
by
Michael Croft
SHIRLEY, NY, UNITED STATES - Sep 15, 2020 - Profacgen, a state-of-the-art protein service provider based in New York, established its own bioinformatics platform, which has emerged as a very sophisticated scientific infrastructure for bioinformatics involving computational facilities, to help explore, understand and analyze complex biological data in various biotechnological programs and projects
Full story
-
Sep 14, 2020, 10:25 AM
by
Michael Croft
CAMBRIDGE, MA, UNITED STATES - Sep 14, 2020 - HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in immunomodulation, today announced a partnership agreement with South Korea-based ABL Bio to advance HFB30132A, a SARS-CoV-2 neutralizing antibody for the treatment of COVID-19 patients
Full story
-
Sep 14, 2020, 09:35 AM
by
Michael Croft
LONDON, UNITED KINGDOM - Sep 14, 2020 - WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited (Wren), a successful and growing clinical nursing healthcare provider in the EU
Full story
-
Sep 14, 2020, 05:48 AM
by
Michael Croft
CAMBRIDGE, UNITED KINGDOM - Sep 14, 2020 - Check4Cancer, the provider of early cancer detection and genetic services, has launched its new brand and website bringing together all of its cancer services onto one platform
Full story
-
Sep 14, 2020, 01:25 AM
by
Michael Croft
Bio-IT World | NIH contracts to explore radiation countermeasures, Alzheimer’s medication, and convalescent plasma, Mission Bio gets $70M for single cell multi-omics technology, and more.
Full story
-
Sep 11, 2020, 06:20 AM
by
Michael Croft
Bio-IT World | Japanese researchers argue there is no cytokine storm, computer-designed protective proteins, ELISA test for antibodies, COVID-19’s impact on Black and Hispanic communities, a “burstier” model of disease spread, and new biomarkers for elevated risk. Plus, the International Vaccine Institute preps with Gates money, 3M funds vaccine researcher, and more.
Full story
-
Sep 11, 2020, 06:08 AM
by
Michael Croft
CAMBRIDGE, UNITED KINGDOM - Sep 11, 2020 - SciBite, the award-winning semantic technology company, today announced the launch of SciBiteAI, a state-of-the-art Artificial Intelligence software platform for leveraging machine learning models alongside semantic technologies to unlock insights into Life Sciences data
Full story
-
Sep 10, 2020, 13:05 PM
by
Michael Croft
FRAMINGHAM, MA, UNITED STATES - Sep 9, 2020 - Palo Alto Networks remediated vulnerabilities in PAN-OS (operating systems version 8.1 or later), which is used by Palo Alto Networks next-generation firewalls (NGFW)
Full story
-
Sep 10, 2020, 10:20 AM
by
Michael Croft
MONTREAL, QC, CANADA - Sep 10, 2020 - Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it plans to pursue Phase 3 clinical development of tesamorelin for the treatment of Non-Alcoholic Steatohepatitis (NASH) in the general population
Full story
-
Sep 10, 2020, 10:04 AM
by
Michael Croft
NEW YORK, NY, UNITED STATES - Sep 10, 2020 - In the current pandemic environment, face-to-face physical therapy visits are less viable due to increasing demands on the healthcare system, as well as the enactment of stay-at-home measures and the reticence of patients particularly those from at-risk groups to visit a clinic or hospital setting
Full story
-
Sep 10, 2020, 06:54 AM
by
Michael Croft
CAMBRIDGE, UNITED KINGDOM - Sep 9, 2020 - Optibrium, leading providers of software and services for drug discovery, today announced a peer-reviewed publication, Practical Applications of Deep Learning to Impute Heterogeneous Drug Discovery Data, in the Journal of Chemical Information and Modeling [1]
Full story
-
Sep 10, 2020, 06:49 AM
by
Michael Croft
BISHOP'S STORTFORD, UNITED KINGDOM - Sep 9, 2020 - Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the introduction of eln
Full story
-
Sep 9, 2020, 14:39 PM
by
Michael Croft
NEW YORK, NY - Sep 9, 2020 - Phosplatin Therapeutics, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced the addition to its growing team of Joseph F
Full story
-
Sep 9, 2020, 13:27 PM
by
Michael Croft
BAR HARBOR, ME, UNITED STATES - Sep 9, 2020 - Scientists have long known that chronic stress experienced early in life, or even chronic prenatal exposure to maternal stress hormones in the womb, can shorten lifespan and contribute to age-related chronic diseases like arthritis, asthma, cancer, cardiovascular disease, diabetes, heart disease and even mental illness later in life -- long after the source of stress has been removed
Full story
-
Sep 9, 2020, 09:46 AM
by
Michael Croft
LOUVAIN-LA-NEUVE, BELGIUM - Sep 9, 2020 - European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning by IDDI, a BIOSTATISTICAL AND ECLINICAL SERVICES provider for Pharmaceutical and Biotechnology companies
Full story
-
Sep 9, 2020, 07:20 AM
by
Michael Croft
Bio-IT World | At the Drug Discovery Chemistry Virtual conference, researchers from industry and academia provide a glimpse into the expanse of pharmaceuticals available beyond Lipinski’s Rule of 5, an endeavor that will hopefully enable the development of much more specific agents with vastly expanded targetable options.
Full story
-
Sep 8, 2020, 15:11 PM
by
Michael Croft
LONDON, UK - Sep 8, 2020 - Lifebit Biotech announced today the appointment of Frank Seo, who joins the company as General Manager
Full story
-
Sep 8, 2020, 13:10 PM
by
Michael Croft
Bio-IT World A newly developed translatable components regression (TransComp-R) model, developed by researchers from Purdue University and the Massachusetts Institute of Technology (MIT), recently identified an overlooked biological mechanism possibly responsible for resistance to the drug infliximab commonly prescribed to patients with inflammatory bowel disease (IBD).
Full story
-
Sep 8, 2020, 04:57 AM
by
Michael Croft
SALUGGIA, ITALY AND HAIFA, ISRAEL - Sep 8, 2020 -
DiaSorin (FTSE MIB: DIA) and MeMed have announced today the creation of a strategic partnership to accelerate the deployment of a novel, host-protein signature-based assay
Full story
-
Sep 7, 2020, 02:06 AM
by
Michael Croft
SHIRLEY, NY, UNITED STATES - Sep 9, 2020 - Chelating agents are chemical compounds that react with metal ions to form a stable, water-soluble complex
Full story